Middle East Healthcare Co (SAU:4009) Marketable Securities: ﷼0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4009 Middle East Healthcare Co SAU:4009
80 GF Score
Price ﷼33.08
GF Value ﷼77.05
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Middle East Healthcare Co Marketable Securities?

Middle East Healthcare Co SAU:4009 +0.36% 80 Marketable Securities is ﷼0 Mil as of Jun. 2026. GuruFocus rates SAU:4009 with a GF Score™ of 80/100 and a GF Value™ of ﷼77.05 (Possible Value Trap). The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Middle East Healthcare Co's Marketable Securities for the quarter that ended in Jun. 2026 was ﷼0 Mil.

Middle East Healthcare Co  (SAU:4009) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Middle East Healthcare Co Marketable Securities Related Terms

Middle East Healthcare Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Middle East Healthcare Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Middle East Healthcare Co Marketable Securities Chart

Middle East Healthcare Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Middle East Healthcare Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SAU:4009
80GF Score
Middle East Healthcare Co SAU:4009
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Middle East Healthcare Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ﷼0 Mil mean?
Middle East Healthcare Co (SAU:4009) has a Marketable Securities of ﷼0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Middle East Healthcare Co and its competitors.
Is Middle East Healthcare Co's Marketable Securities too high?
Middle East Healthcare Co's current Marketable Securities is ﷼0 Mil. Overall, Middle East Healthcare Co has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Middle East Healthcare Co's Marketable Securities compare to HCA and THC?
Middle East Healthcare Co's Marketable Securities of ﷼0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Middle East Healthcare Co and its competitors. Middle East Healthcare Co's current Marketable Securities is ﷼0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Middle East Healthcare Co (SAU:4009) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼77.05, compared to a current price of ﷼33.08 — trading 57.1% below its estimated fair value. The current Marketable Securities is ﷼0 Mil. Middle East Healthcare Co's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Middle East Healthcare Co (SAU:4009), the current Marketable Securities is ﷼0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Middle East Healthcare Co (SAU:4009) Overvalued in 2026?

Based on GuruFocus' analysis, Middle East Healthcare Co stock appears to be undervalued. The current stock price of ﷼33.08 is trading 57.1% below its estimated GF Value™ of ﷼77.05. GuruFocus considers Middle East Healthcare Co to be Possible Value Trap.

Key valuation signals for SAU:4009:

  • Marketable Securities: ﷼0 Mil
  • GF Value™: ﷼77.05 vs. price of ﷼33.08 (57.1% below fair value)
  • GF Score™: 80/100 with 6 warning signs

No single metric tells the full story. See the SAU:4009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Middle East Healthcare Co Business Description

Address 4, Batterjee Road, P.O.Box 2550, Al-Zahra District, Jeddah, SAU, 21461
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company. The company's reportable segments are Inpatient Services, Outpatient Services, Pharmacy Sales and Others. The majority of revenue is derived from the Inpatient Services segment.
80GF Score

Get the complete analysis for SAU:4009

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼33.08
Price
﷼77.05
GF Value